Triple negative breast cancer (TNBC) is an aggressive form of breast cancer that is negative for estrogen, progesterone, and human epidermal growth factor (HER2) receptors…
Triple negative breast cancer (TNBC) presents one of the most aggressive and difficult to treat breast cancer subtypes as these cancer cells lack three receptors: estrogen, progesterone, and human epidermal growth factor receptor 2…
It is a worrying fact that chemotherapeutic options for treating triple negative breast cancer are limited in nature, including cisplatin, which has been reported to have various side effects during chemotherapeutic treatment on the patient…